by editor | Oct 3, 2011 | Latest Spotlights, Medical Stocks
Intellect Neurosciences, Inc and ViroPharma Announce $126.5 Million Global Licensing Agreement to Develop and Commercialize OX1 for Friedreich’s Ataxia and Other Neurodegenerative Diseases Intellect to Receive Upfront Payment of $6.5 Million, Potential Milestone...
by editor | Sep 16, 2010 | Latest Spotlights, StockGuru Blog
StockGuru Spotlight September 16, 2010 SOTR, SDNY, AXIH, YESD, ILNS, USAE, PFTI Dear Members: We have seen strong upward momentum in Ruby Creek all summer long. This was an original StockGuru Spotlight on June 17, 2010, when it was trading at $0.39. We Spotlighted...
by editor | Sep 16, 2010 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Intellect Neurosciences Inc. (OTCBB: ILNS) is in the StockGuru Spotlight. Intellect Neurosciences Inc. is a Manhattan-based biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic...
by editor | Aug 10, 2010 | Latest Spotlights, StockGuru Blog
StockGuru Spotlight August 10, 2010 BROE, UEEC, ILNS, PCYG, ISDR, ELRA, GRXM Dear Members: Our Stock Guru Picks are based on recent news releases — and we prove our picks are real by issuing press releases on the date of the pick. We link you to those releases....
by editor | Aug 9, 2010 | Latest Spotlights, StockGuru Blog
DALLAS, TEXAS : StockGuru announces that Intellect Neurosciences Inc. (OTCBB: ILNS) is in the StockGuru Spotlight. Intellect Neurosciences, Inc. is a Manhattan-based biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic...